Artificial Intelligence can play an exciting role in Infectious Disease drug discovery. Learn more about how #AI can deliver transformational data analysis in our recent article in @Pharmafocus , written by Liam Tremble, PhD Project Manager, R&D Operations https://bit.ly/31UZFbz
Continue readingRNA sequencing ahead of pioneering AI analysis programme 7 October 2021 – Poolbeg Pharma (AIM: POLB), Poolbeg’ or the ‘Company’, a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has partnered with leading global biopharma services company, Eurofins Genomics (‘Eurofins’), to complete RNA sequencing for Poolbeg of Respiratory Syncytial Virus (RSV) disease progression samples from human viral challenge studies. This deep sequencing work is a key step leading to Poolbeg commencing…
Continue reading
